The landscape of dementia diagnosis has progressed considerably with the advent of complex biomarkers, which includes amyloid PET scans, tau imaging, and blood-centered tests that will detect Alzheimer's pathology decades prior to indicators arise. While these technological developments depict remarkable progress in knowing neurodegenerative disord